Explore the words cloud of the MISTRAL project. It provides you a very rough idea of what is the project "MISTRAL" about.
The following table provides information about the project.
FUNDACIO PRIVADA INSTITUT DE RECERCA DE LA SIDA-CAIXA
|Coordinator Country||Spain [ES]|
|Total cost||9˙994˙383 €|
|EC max contribution||9˙994˙383 € (100%)|
1. H2020-EU.3.1.3. (Treating and managing disease)
|Duration (year-month-day)||from 2020-01-01 to 2024-12-31|
Take a look of project's partnership.
|1||FUNDACIO PRIVADA INSTITUT DE RECERCA DE LA SIDA-CAIXA||ES (BARCELONA)||coordinator||3˙967˙500.00|
|2||KAROLINSKA INSTITUTET||SE (STOCKHOLM)||participant||1˙490˙833.00|
|3||REGION HOVEDSTADEN||DK (HILLEROD)||participant||1˙017˙611.00|
|4||UNIVERSITE D'AIX MARSEILLE||FR (Marseille)||participant||730˙470.00|
|5||CASE WESTERN RESERVE UNIVERSITY CORPORATION||US (CLEVELAND OHIO)||participant||727˙787.00|
|6||AELIX THERAPEUTICS SL||ES (BARCELONA)||participant||534˙978.00|
|7||FUNDACION PRIVADA INSTITUTO DE SALUD GLOBAL BARCELONA||ES (BARCELONA)||participant||448˙021.00|
|8||CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER||ES (BARCELONA)||participant||351˙762.00|
|9||ASPHALION SL||ES (BARCELONA)||participant||316˙187.00|
|10||PROJECTE DELS NOMS - HISPANOSIDA ASOCIACION||ES (BARCELONA)||participant||236˙737.00|
|11||VEDANTA BIOSCIENCES INC||US (WILMINGTON)||participant||172˙493.00|
The HIV/AIDS pandemic continues to be one of the major health challenges ever faced by mankind. Far from being resolved, HIV is soaring in Eastern Europe (60% increase in new infections and 27% increase in deaths since 2010) and other regions of the world despite increasing access to antiretroviral treatment. There is emerging evidence that the human microbiome impacts some of the most important clinical aspects of HIV-1 infection, including immune disorders, chronic inflammation and accelerated aging. Work in other viral diseases and cancer immunotherapy suggest a critical role of the human microbiome also in the outcome of immune therapeutic interventions in HIV-1 infection. The MISTRAL project brings together a team of world-class HIV and microbiome researchers and SMEs with ideal complementary knowledge and expertise. This team will work to discover and validate novel gut microbiome biomarkers to inform rationally-designed, mechanistically-driven interventions on the gut microbiome to mitigate HIV-1 acquisition, systemic inflammation, chronic clinical complications, antimicrobial drug resistance, and boost the efficacy of HIV cure immunotherapies. Integrated and curated large microbiome and host datasets generated during the execution of the project will be made public through a freely accessible, specifically-dedicated web-based repository. Biomarker discoveries will be incorporated into a cloud-based software tool that will automate microbiome analyses and interpretations, thus streamlining patient stratification for clinical and research purposes. If successful, MISTRAL will benefit millions of human beings living with, or at risk of acquiring HIV-1 infection, and will produce novel concepts and technical innovations applicable to other human diseases. By doing that, MISTRAL will help to unlock the full clinical potential of the human microbiome to stratify patient outcomes and will irreversibly bring microbiome science closer to clinical practice.
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "MISTRAL" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (email@example.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "MISTRAL" are provided by the European Opendata Portal: CORDIS opendata.
PanCareFollowUp: Novel, patient-centred survivorship care to improve care quality, effectiveness, cost-effectiveness and accessibility for survivors and caregiversRead More
CeLac and European consortium for a personalized medicine approach to Gastric CancerRead More
Global Alliance for Chronic Diseases SecretariatRead More